HAL
48
-3
AEP
54
6
WHR
65
-5
TGNA
50
-6
DLTR
38
-4
SLB
52
-3
CAH
48
-6
GRMN
67
-4
STX
45
-4
CB
57
2
ZTS
47
2
TJX
62
-2
CMG
66
-4
ILMN
32
-9
PCAR
56
-5
WBA
43
-4
DGX
48
11
WYNN
36
-5
NWSA
62
-7
WEC
53
5
HAL
48
-3
AEP
54
6
WHR
65
-5
TGNA
50
-6
DLTR
38
-4
SLB
52
-3
CAH
48
-6
GRMN
67
-4
STX
45
-4
CB
57
2
ZTS
47
2
TJX
62
-2
CMG
66
-4
ILMN
32
-9
PCAR
56
-5
WBA
43
-4
DGX
48
11
WYNN
36
-5
NWSA
62
-7
WEC
53
5
Financhill
Back

Calamos Convertible Equity Alt ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
91

CVRT
Calamos Convertible Equity Alt ETF

Last Price:
30.61
Seasonality Move:
15.45%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
91
Calamos Convertible Equity Alt ETF (CVRT) is a Buy

Is Calamos Convertible Equity Alt ETF a Buy, Sell or Hold?

  • The current Calamos Convertible Equity Alt ETF [CVRT] share price is $30.46. The Score for CVRT is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
  • CVRT is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CVRT Stock Price Chart

What is Calamos Convertible Equity Alt ETF's stock price today?

  • The Calamos Convertible Equity Alt ETF share price today is $30.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CVRT is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CVRT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.56 Buy
Relative Strength Index (14 RSI): 65.79 Buy
Chaikin Money Flow: 1210 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.67 - 30.23) Buy
Bollinger Bands (100): (26.85 - 29.11) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CVRT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.5 Sell
20-day SMA: 29.51 Buy
50-day SMA: 28.79 Buy
200-day SMA: 27.5 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.75 Buy
50-day EMA: 28.97 Buy
200-day EMA: 27.48 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Calamos Convertible Equity Alt ETF Earnings Growth & CVRT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Calamos Convertible Equity Alt ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):